Study identifier:SH-SBC-0011
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Study to investigate the effect of food on PK and safety of AZ242 (single oreal dose of 3 mg) in healthy male Japanese subjects
Diabetes Mellitus
Phase 1
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
-
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|